17-81528579-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_012418.4(FSCN2):c.48C>T(p.Leu16=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,608,430 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0016 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0017 ( 3 hom. )
Consequence
FSCN2
NM_012418.4 synonymous
NM_012418.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.85
Genes affected
FSCN2 (HGNC:3960): (fascin actin-bundling protein 2, retinal) This gene encodes a member of the fascin protein family. Fascins crosslink actin into filamentous bundles within dynamic cell extensions. This family member is proposed to play a role in photoreceptor disk morphogenesis. A mutation in this gene results in one form of autosomal dominant retinitis pigmentosa and macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-81528579-C-T is Benign according to our data. Variant chr17-81528579-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 289847.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-81528579-C-T is described in Lovd as [Likely_benign]. Variant chr17-81528579-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.86 with no splicing effect.
BS2
High AC in GnomAd4 at 245 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSCN2 | NM_012418.4 | c.48C>T | p.Leu16= | synonymous_variant | 1/5 | ENST00000417245.7 | NP_036550.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSCN2 | ENST00000417245.7 | c.48C>T | p.Leu16= | synonymous_variant | 1/5 | 1 | NM_012418.4 | ENSP00000388716 | P1 | |
FSCN2 | ENST00000334850.7 | c.48C>T | p.Leu16= | synonymous_variant | 1/5 | 5 | ENSP00000334665 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 244AN: 152238Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
244
AN:
152238
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00197 AC: 468AN: 238072Hom.: 2 AF XY: 0.00215 AC XY: 279AN XY: 129922
GnomAD3 exomes
AF:
AC:
468
AN:
238072
Hom.:
AF XY:
AC XY:
279
AN XY:
129922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2478AN: 1456074Hom.: 3 Cov.: 32 AF XY: 0.00170 AC XY: 1234AN XY: 723874
GnomAD4 exome
AF:
AC:
2478
AN:
1456074
Hom.:
Cov.:
32
AF XY:
AC XY:
1234
AN XY:
723874
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00161 AC: 245AN: 152356Hom.: 0 Cov.: 34 AF XY: 0.00177 AC XY: 132AN XY: 74506
GnomAD4 genome
AF:
AC:
245
AN:
152356
Hom.:
Cov.:
34
AF XY:
AC XY:
132
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | FSCN2: BP4, BP7 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 15, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at